Literature DB >> 21844746

Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study.

Maria Trent1, Debra Bass, Roberta B Ness, Catherine Haggerty.   

Abstract

PEACH trial data were used to evaluate the relationship between subsequent sexually transmitted infection and recurrent pelvic inflammatory disease on infertility and chronic pelvic pain (CPP). Recurrent pelvic inflammatory disease was associated with an almost 2-fold increase in infertility and more than 4-fold increase in CPP. Subsequent sexually transmitted infection was associated with CPP, but not infertility.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21844746      PMCID: PMC4425210          DOI: 10.1097/OLQ.0b013e31821f918c

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  17 in total

1.  Chlamydia and its effect on reproduction.

Authors:  L V Westrom
Journal:  J Br Fer Soc       Date:  1996

2.  Pelvic inflammatory disease: guidelines for prevention and management.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1991-04-26

3.  Sexually transmitted diseases treatment guidelines, 2006.

Authors:  Kimberly A Workowski; Stuart M Berman
Journal:  MMWR Recomm Rep       Date:  2006-08-04

4.  Effect of pelvic inflammatory disease on fertility.

Authors:  L Westrom
Journal:  Venereology       Date:  1995-11

5.  Adverse adolescent reproductive health outcomes after pelvic inflammatory disease.

Authors:  Maria Trent; Catherine L Haggerty; Jacky M Jennings; Sunghee Lee; Debra C Bass; Roberta Ness
Journal:  Arch Pediatr Adolesc Med       Date:  2011-01

6.  Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.

Authors:  Roberta B Ness; David E Soper; Robert L Holley; Jeffrey Peipert; Hugh Randall; Richard L Sweet; Steven J Sondheimer; Susan L Hendrix; Antonio Amortegui; Giuliana Trucco; Thomas Songer; Judith R Lave; Sharon L Hillier; Debra C Bass; Sheryl F Kelsey
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

Review 7.  Colonization of the endometrium and fallopian tubes with Ureaplasma urealyticum.

Authors:  R L Sweet
Journal:  Pediatr Infect Dis       Date:  1986 Nov-Dec

8.  Results of a randomized controlled trial of a brief behavioral intervention for pelvic inflammatory disease in adolescents.

Authors:  Maria Trent; Shang-en Chung; Michael Burke; Allen Walker; Jonathan M Ellen
Journal:  J Pediatr Adolesc Gynecol       Date:  2009-09-03       Impact factor: 1.814

9.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

10.  Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease.

Authors:  Catherine L Haggerty; Patricia A Totten; Sabina G Astete; Roberta B Ness
Journal:  Infect Dis Obstet Gynecol       Date:  2006
View more
  19 in total

Review 1.  Pelvic inflammatory disease.

Authors:  Maria Trent
Journal:  Pediatr Rev       Date:  2013-04

Review 2.  Status of adolescent pelvic inflammatory disease management in the United States.

Authors:  Maria Trent
Journal:  Curr Opin Obstet Gynecol       Date:  2013-10       Impact factor: 1.927

3.  Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia.

Authors:  Caroline M Mitchell; Gloria E Anyalechi; Craig R Cohen; Catherine L Haggerty; Lisa E Manhart; Sharon L Hillier
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 7.759

4.  Using Innovation to Address Adolescent and Young Adult Health Disparities in Pelvic Inflammatory Disease: Design of the Technology Enhanced Community Health Precision Nursing (TECH-PN) Trial.

Authors:  Maria Trent; Jamie Perin; Julia Rowell; Maunank Shah; Jennifer Anders; Pamela Matson; Rebecca M Brotman; Jacques Ravel; Phyllis Sharps; Richard Rothman; Hasiya E Yusuf; Charlotte A Gaydos
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 7.759

5.  Factors associated with pelvic inflammatory disease: A case series analysis of family planning clinic data.

Authors:  Sally Sweeney; Deborah Bateson; Kirsteen Fleming; Wilhelmina Huston
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

6.  Care-Seeking Behavior After Notification Among Young Women With Recurrent Sexually Transmitted Infections After Pelvic Inflammatory Disease.

Authors:  Arlene M Butz; Charlotte Gaydos; Shang-En Chung; Betty H Johnson; Steven Huettner; Maria Trent
Journal:  Clin Pediatr (Phila)       Date:  2016-08-08       Impact factor: 1.168

7.  Recruitment of Minority Adolescents and Young Adults into Randomised Clinical Trials: Testing the Design of the Technology Enhanced Community Health Nursing (TECH-N) Pelvic Inflammatory Disease Trial.

Authors:  Maria Trent; Shang-En Chung; Charlotte Gaydos; Kevin D Frick; Jennifer Anders; Steven Huettner; Richard Rothman; Arlene Butz
Journal:  Eur Med J Reprod Health       Date:  2016-08

8.  Understanding consumer preferences for care of adolescents with pelvic inflammatory disease.

Authors:  Maria Trent; Harold Lehmann; Arlene Butz; Carol Thompson; Qiang Qian; Kevin D Frick
Journal:  Med Ther Med Reprod Gynecol Endocrinol       Date:  2013 Oct-Dec

9.  Brazilian Protocol for Sexually Transmitted infections, 2020: pelvic inflammatory disease.

Authors:  Maria Luiza Bezerra Menezes; Paulo Cesar Giraldo; Iara Moreno Linhares; Neide Aparecida Tosato Boldrini; Mayra Gonçalves Aragon
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

10.  Modernization, sexual risk-taking, and gynecological morbidity among Bolivian Forager-horticulturalists.

Authors:  Jonathan Stieglitz; Aaron D Blackwell; Raúl Quispe Gutierrez; Edhitt Cortez Linares; Michael Gurven; Hillard Kaplan
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.